CD47 and neoplasm: In breast cancer, Wnt signaling drives cell proliferation and metastasis and was recently shown to suppress the anti-tumor immune response [20], for example, through its major target, Myc, that activates expression of cell antigens (e.g., CD47), preventing tumor cell recognition by the immune cells [23].